^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    davoceticept (ALPN-202)

    i
    Other names: ALPN-202, ALPN 202
    Associations
    News
    Trials
    Company:
    Vertex
    Drug class:
    CTLA4 antagonist, CD28 stimulant, PD-L1 antagonist
    Related drugs:
    Associations
    News
    Trials